Načítá se...
Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy
BACKGROUND: There is evidence that implantable cardioverter‐defibrillator (ICD) for primary prevention in people with an ischaemic cardiomyopathy improves survival rate. The evidence supporting this intervention in people with non‐ischaemic cardiomyopathy is not as definitive, with the recently publ...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517305/ https://ncbi.nlm.nih.gov/pubmed/30537022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012738.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|